Trio Plans Anti-COVID-19 Vaccine Derived From Simian Adenoviruses

Comprises Italy’s ReiThera, Germany’s Leukocare, Belgium’s Univercel

Science_Lab_Covid19
Vaccine based on ReiThera-proprietary chimpanzee adenoviral vector • Source: Shutterstock

More from Clinical Trials

More from R&D